Patents by Inventor Feng-Lin Chiang

Feng-Lin Chiang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF USING ANTI-PSGL-1 ANTIBODIES IN COMBINATION WITH JAK INHIBITORS TO TREAT T-CELL MEDIATED INFLAMMATORY DISEASES OR CANCERS
    Publication number: 20230149544
    Abstract: Provided herein are methods of treating or preventing a T-cell mediated inflammatory disease or cancer in a subject in need thereof comprising administering to the subject a therapeutically effective amount of an antibody that specifically binds to human PSGL-1 in combination with a Janus kinase (JAK) inhibitor. In some embodiments, the T-cell mediated inflammatory disease is GVHD, e.g., acute GVHD or chronic GVHD.
    Type: Application
    Filed: November 16, 2022
    Publication date: May 18, 2023
    Applicant: AltruBio Inc.
    Inventors: Shih-Yao LIN, Feng-Lin CHIANG, You-Chia YEH
  • Anti-folate receptor alpha (FRA) antibody-drug conjugates and methods of using thereof
    Patent number: 9950077
    Abstract: The present disclosure provides anti-folate receptor alpha (FRA) antibody-drug conjugates comprising a hydrophilic self-immolative linker. The present disclosures further provide compositions and methods for treating cancers.
    Type: Grant
    Filed: June 19, 2015
    Date of Patent: April 24, 2018
    Assignees: BIOALLIANCE C.V., ABGENOMICS INTERNATIONAL INC.
    Inventors: Rong-Hwa Lin, Shih-Yao Lin, Yu-Chi Hsieh, Chiu-Chen Huang, Shu-Hua Lee, Yu-Ying Tsai, Feng-Lin Chiang, Li-An Hu
  • ANTI-FOLATE RECEPTOR ALPHA (FRA) ANTIBODY-DRUG CONJUGATES AND METHODS OF USING THEREOF
    Publication number: 20160015827
    Abstract: The present disclosure provides anti-folate receptor alpha (FRA) antibody-drug conjugates comprising a hydrophilic self-immolative linker. The present disclosures further provide compositions and methods for treating cancers.
    Type: Application
    Filed: June 19, 2015
    Publication date: January 21, 2016
    Inventors: Rong-Hwa LIN, Shih-Yao LIN, Yu-Chi HSIEH, Chiu-Chen HUANG, Shu-Hua LEE, Yu-Ying TSAI, Feng-Lin CHIANG, Li-An HU
  • ANTI-EPCAM ANTIBODIES THAT INDUCE APOPTOSIS OF CANCER CELLS AND METHODS USING SAME
    Publication number: 20110165161
    Abstract: The present invention provides antibodies (such as chimeric and humanized antibodies) specifically bind to epithelial cell adhesion/activating molecule EpCAM expressed on cancer cells and induce cancer cell apoptosis. In addition, the present invention also provides use of the antibodies described herein for diagnostic and therapeutic purposes.
    Type: Application
    Filed: December 23, 2010
    Publication date: July 7, 2011
    Inventors: Shih-Yao LIN, Leewen Lin, Feng-Lin Chiang, Shu-Hua Lee, Yu-Ying Tsai